首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Hybrid molecules between benzenesulfonamides and active antimicrobial benzo(d)isothiazol-3-ones.
【24h】

Hybrid molecules between benzenesulfonamides and active antimicrobial benzo(d)isothiazol-3-ones.

机译:苯磺酰胺和活性抗菌剂苯并(d)异噻唑-3-酮之间的杂化分子。

获取原文
获取原文并翻译 | 示例
           

摘要

Novel hybrid molecules between benzenesulfonamides and active antimicrobial 2-amino-benzo[d]isothiazol-3-ones were synthesized and characterised and their in vitro antimicrobial activity was evaluated by the minimal inhibitory concentration (MIC). The compounds exhibit moderate antibacterial properties against gram-positive bacteria (MIC 6-100 microg ml(-1)) such as several bacilli, staphylococci and streptococci, including methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis strains, while no inhibition of gram-negative Escherichia coli is detected up to the concentration of 100 microg ml(-1). Synergistic inhibitory activity occurs when sulfanilamides 4a and 4c are tested in combination with trimethoprim against S. aureus. Concerning antifungal properties, only compound 4c is able to inhibit the growth of Saccharomyces cerevisiae and Cryptococcus neoformans yeasts and several dermatophytes. Structure-activity relationships are discussed.
机译:合成和表征了苯磺酰胺与活性抗菌剂2-氨基-苯并[d]异噻唑-3-酮之间的新型杂合分子,并通过最小抑菌浓度(MIC)评估了它们的体外抗菌活性。这些化合物对革兰氏阳性菌(MIC 6-100 microg ml(-1))具有适度的抗菌性能,例如几种杆菌,葡萄球菌和链球菌,包括耐甲氧西林的金黄色葡萄球菌和表皮葡萄球菌菌株,而对革兰氏阴性菌没有抑制作用检出的大肠杆菌浓度高达100微克ml(-1)。当将磺胺酰胺4a和4c与甲氧苄氨嘧啶联用测试抗金黄色葡萄球菌时,会产生协同抑制活性。关于抗真菌特性,仅化合物4c能够抑制酿酒酵母和新隐隐球菌酵母和几种皮肤真菌的生长。讨论了构效关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号